Grantham, Mayo, Van Otterloo & Co (GMO)’s Amalgamated Financial AMAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-30,017
Closed -$483K 575
2023
Q2
$483K Hold
30,017
﹤0.01% 563
2023
Q1
$531K Buy
30,017
+10,300
+52% +$227K ﹤0.01% 558
2022
Q4
$454K Sell
19,717
-1,900
-9% -$46K ﹤0.01% 595
2022
Q3
$487K Sell
21,617
-14,708
-40% -$330K ﹤0.01% 575
2022
Q2
$719K Hold
36,325
﹤0.01% 563
2022
Q1
$653K Hold
36,325
﹤0.01% 569
2021
Q4
$609K Hold
36,325
﹤0.01% 579
2021
Q3
$575K Hold
36,325
﹤0.01% 582
2021
Q2
$568K Sell
36,325
-1,200
-3% -$19.4K ﹤0.01% 601
2021
Q1
$623K Sell
37,525
-4,775
-11% -$77.4K ﹤0.01% 662
2020
Q4
$581K Sell
42,300
-31,500
-43% -$401K ﹤0.01% 659
2020
Q3
$781K Buy
73,800
+1,500
+2% +$17.5K 0.01% 561
2020
Q2
$914K Buy
72,300
+700
+1% +$7.42K 0.01% 548
2020
Q1
$775K Buy
71,600
+53,100
+287% +$851K 0.01% 537
2019
Q4
$360K Buy
+18,500
New +$341K ﹤0.01% 618

Other funds holding AMAL

Grantham, Mayo, Van Otterloo & Co (GMO)'s AMAL Position: Q3 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Amalgamated Financial (AMAL) in Q3 2023, closing a stake of 30,017 shares — an estimated $483K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in AMAL in Q4 2019 and held it in 15 quarters. The position peaked at $914K in Q2 2020. 114 funds tracked by Wall St. Rank hold AMAL as of Q3 2023.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Amalgamated Financial position as of Q3 2023 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 30,017 Amalgamated Financial shares in Q3 2023, an estimated $483K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Amalgamated Financial in Q4 2019 and held it in 15 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Amalgamated Financial position peaked at $914K in Q2 2020.
  • 114 funds tracked by Wall St. Rank held Amalgamated Financial as of Q3 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2023, filed 13 Nov 2023.